- Previous Close
1.7500 - Open
1.7900 - Bid 1.6700 x --
- Ask 1.6900 x --
- Day's Range
1.6700 - 1.8300 - 52 Week Range
1.5300 - 3.5800 - Volume
214,738 - Avg. Volume
178,258 - Market Cap (intraday)
580.606M - Beta (5Y Monthly) 1.99
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7100 - Earnings Date Nov 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.38
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.
www.crescolabs.com2,900
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Drug Manufacturers - Specialty & Generic
Industry
Recent News: CL.CN
View More
Performance Overview: CL.CN
Trailing total returns as of 2024-11-08, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CL.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CL.CN
View MoreValuation Measures
Market Cap
608.42M
Enterprise Value
1.40B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.93
Enterprise Value/Revenue
1.35
Enterprise Value/EBITDA
82.54
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.47%
Return on Assets (ttm)
4.81%
Return on Equity (ttm)
-35.12%
Revenue (ttm)
734.82M
Net Income Avi to Common (ttm)
-172.46M
Diluted EPS (ttm)
-0.7100
Balance Sheet and Cash Flow
Total Cash (mrq)
112.3M
Total Debt/Equity (mrq)
182.14%
Levered Free Cash Flow (ttm)
58.06M